People · Operator
Named in public records as an officer, director or promoter · active 2021–2025 · Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aromyx Corp | — | Other Technology | Series A | $11.9M | $220.7M | 2021 |
| Califia Pharma, Inc. | — | Pharmaceuticals | Seed | $4.4M | $8.5M | 2025 |
Clint J. Korver at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Clint J. Korver on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Josh Silverman | 1 | 2 |
| Joe J. Gatto | 1 | 1 |
| Shaun J. Lonergan | 1 | 1 |
| Mark J. Mendel | 1 | 1 |
| Christopher J. Hanson | 1 | 1 |
| Kieran J. Furlong | 1 | 1 |
| Jeffrey Y. Suto | 1 | 1 |
| Michael J. Kelner | 1 | 1 |
| Keith J. Milne | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.